Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026.